Every record from VendorInvestigate · page 3
The only contributor that routinely purchases material anonymously rather than accepting submitted samples. Measured offset against the reference laboratory is -0.493 pp on 380 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043080 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.05 | 4.22 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042299 | AOD-9604 | HJ | HJ-2601-N2483 | 2026-Q2 | 98.14 | 5.21 | 103.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042696 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.42 | 3.62 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043145 | Enclomiphene citrate | SSA | SSA-2603-C6950 | 2026-Q2 | 97.73 | 3.64 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-042915 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.03 | 5.21 | 96.7 | Buyer-sourced | 0 | PASS |
| AX-2026-043278 | Hexarelin | CPC | CPC-2511-F1491 | 2026-Q2 | 98.58 | 5.08 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043043 | Hexarelin | KP | KP-2604-X5435 | 2026-Q2 | 98.54 | 3.33 | 107.2 | Buyer-sourced | 2 | FAIL |
| AX-2026-041815 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 96.86 | 6.01 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-043020 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.27 | 7.27 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042850 | Retatrutide | GGPeps | GGPE-2511-X1688 | 2026-Q2 | 97.14 | 5.89 | 95.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042966 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.59 | 5.46 | 106.2 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042632 | Semaglutide | GGPeps | GGPE-2603-W8751 | 2026-Q2 | 98.15 | 3.78 | 104.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041213 | NAD+ | WWB | WWB-2601-V1583 | 2026-Q2 | 99.04 | 11.41 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-043075 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.21 | 4.07 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043300 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 97.16 | 1.80 | 97.5 | Laboratory-retained | 0 | PASS |
| AX-2026-042469 | Semaglutide | SWB | SWB-2603-T5632 | 2026-Q2 | 97.65 | 6.97 | 96.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042818 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 99.03 | 4.95 | 101.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041525 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.48 | 2.86 | 103.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043044 | Hexarelin | KP | KP-2604-X5435 | 2026-Q2 | 98.00 | 3.78 | 107.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-043453 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 97.11 | 5.11 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043015 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.27 | 7.64 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042603 | Tirzepatide | GGPeps | GGPE-2604-H8313 | 2026-Q2 | 98.64 | 1.80 | 94.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043083 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.54 | 3.89 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042987 | Desmopressin | KP | KP-2512-U5139 | 2026-Q2 | 98.35 | 2.86 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041595 | TB-500 | QSC | QSC-2601-V7307 | 2026-Q2 | 99.54 | 3.91 | 99.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041393 | Adipotide | WWB | WWB-2512-R4093 | 2026-Q2 | 98.32 | 3.35 | 98.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043476 | GHRP-6 | WXT | WXT-2604-M5964 | 2026-Q2 | 98.18 | 3.83 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041949 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 98.74 | 9.12 | 99.9 | Buyer-sourced | 0 | PASS |
| AX-2026-041858 | ARA-290 | JEEP | JEEP-2601-K3139 | 2026-Q2 | 98.82 | 4.14 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041854 | ARA-290 | JEEP | JEEP-2601-K3139 | 2026-Q2 | 98.69 | 3.84 | 107.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043072 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.18 | 3.69 | 96.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042301 | AOD-9604 | HJ | HJ-2601-N2483 | 2026-Q2 | 98.60 | 5.36 | 97.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043272 | Hexarelin | CPC | CPC-2511-F1491 | 2026-Q2 | 98.25 | 5.36 | 100.1 | Buyer-sourced | 2 | FAIL |
| AX-2026-043014 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.89 | 7.79 | 93.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041528 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.73 | 2.23 | 93.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041294 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 98.98 | 6.20 | — | Buyer-sourced | 3 | FAIL |
| AX-2026-042435 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.54 | 3.91 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041366 | Semaglutide | WWB | WWB-2512-T3671 | 2026-Q2 | 98.91 | 2.24 | 101.3 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042826 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 99.19 | 5.07 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043026 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.89 | 7.77 | 105.5 | Buyer-sourced | 1 | MARGINAL |